Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders
about
Neuroinflammation and psychiatric illnessInflammation Models of Depression in Rodents: Relevance to Psychotropic Drug DiscoveryPreclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonistBeyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive ReviewEffects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell functionThe Research Domain Criteria (RDoC) Project and Studies of Risk and Resilience in Maltreated ChildrenIntermediate phenotypes and biomarkers of treatment outcome in major depressive disorderGABA in the insula - a predictor of the neural response to interoceptive awarenessThe stressed synapse: the impact of stress and glucocorticoids on glutamate transmissionClinical and molecular genetics of psychotic depressionTargeting the glutamatergic system to treat major depressive disorder: rationale and progress to dateSignal Transduction in Astrocytes during Chronic or Acute Treatment with Drugs (SSRIs, Antibipolar Drugs, GABA-ergic Drugs, and Benzodiazepines) Ameliorating Mood DisordersKetamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacyImplication of Genetic Deletion of Wdr13 in Mice: Mild Anxiety, Better Performance in Spatial Memory Task, with Upregulation of Multiple Synaptic Proteins.Homer1/mGluR5 activity moderates vulnerability to chronic social stressSCOP/PHLPP1β in the basolateral amygdala regulates circadian expression of mouse anxiety-like behavior.GABAA receptor-acting neurosteroids: a role in the development and regulation of the stress responseR-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effectsStress-induced changes of hippocampal NMDA receptors: modulation by duloxetine treatmentConceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depressionThe Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition.Intergenerational transmission of self-regulation: A multidisciplinary review and integrative conceptual framework.Chronic antidepressant treatment impairs the acquisition of fear extinction.Behavioral and monoamine changes following severe vitamin C deficiencyA role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophreniaUsing an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantineCellular and molecular basis for stress-induced depression.Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift.In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature.Higher Body Iron Is Associated with Greater Depression Symptoms among Young Adult Men but not Women: Observational Data from the Daily Life StudyThe role of genes involved in stress, neural plasticity, and brain circuitry in depressive phenotypes: Convergent findings in a mouse model of neglect.Bright light therapy for depression: a review of its effects on chronobiology and the autonomic nervous system.IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy.Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome.A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy.Inflammation: opportunities for treatment stratification among individuals diagnosed with mood disorders.Biological substrates underpinning diagnosis of major depression.Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?Child abuse, depression, and methylation in genes involved with stress, neural plasticity, and brain circuitryWhy are cortical GABA neurons relevant to internal focus in depression? A cross-level model linking cellular, biochemical and neural network findings.
P2860
Q21245244-9E959E00-BD1F-418A-8695-35B4679B036CQ26749497-9D01F109-B249-4EC0-9ACE-E8FCFD89CB09Q26750021-8138A097-002F-4EAF-9B4F-876752D58E1AQ26782993-7F43EBC8-36AD-48D8-8F06-B4FD62F67FCDQ26783101-201AF0F8-B70B-4BC8-BCE2-63F94396940AQ26799558-1C4F0F23-031F-45F2-B79E-89CFB46479D0Q26823991-BE859652-218B-4EB0-AC79-2D79C34422EDQ26830571-3E69D637-3E99-4555-8C66-6DB457E04BA8Q26859198-FDD0CAB7-70AB-4FDE-AA5A-BC386EF30F58Q27004154-6AADA2F4-ECBB-4BF6-921F-3FC092FFF440Q27004490-68FC9135-71E8-454C-8EBF-193F62CC4E89Q27006485-7D286DAD-411A-474C-AF7F-3BDE28A5A902Q27024227-D4F25F32-7EEF-4292-A39C-4B0519802FEDQ27308729-45C45767-9458-4E22-918F-C305EFD8EEADQ27311111-43B6756C-B404-4446-B5A8-BD3C86778A71Q27347885-1B3D866C-B299-47CC-861A-383C059F2D92Q28241963-FA7C1289-01C0-4DC0-A86E-789BE184503AQ28266846-F146A65E-3C25-4E45-933C-2D5ECBBF7C15Q28729135-456E5A1D-6B42-4004-B591-6669699B21FDQ28830670-C26D20A7-8380-4E2F-A1FC-7B098C5628CEQ30373328-F4AF9129-7120-4684-9484-3F7E80BAC2CFQ30384821-C396594A-3525-45A1-891D-4D4D3CC99BE5Q30437449-92BA90CB-8295-4910-9F54-AED3D376B2BFQ30443638-463A4EEC-5B56-4EA5-B28F-D698175789C9Q30444005-41112699-0C96-4B56-A529-37DAEF4B208BQ30458884-94E8C23A-7F2D-44AB-B7BB-9FEA3E9ECB02Q30836590-898DDE21-FA85-4CC4-839D-55FE59F5D606Q30906677-A9EA4F9A-474B-4788-922A-7A1E21D077ECQ30927398-B8B6D27D-DEAA-4419-BE6B-362EC59C022FQ30982929-CF360DCD-762E-4785-827A-CA6AF2EAB640Q33578754-5D21C675-4658-49EF-839B-ED0EBAB828DFQ33597502-B4929CDA-428D-4390-8B7E-30652B60E1FDQ33620624-4BB401F9-2173-4661-98EE-5AEBAECD7F93Q33635571-A43462B9-13D6-4F39-8223-5912F0CD7DA4Q33658525-3ECC5437-9DFE-45FE-9023-3951BE7CDF3FQ33721019-BD4F76F3-908A-4CD7-949B-C0443DD077BFQ33820463-B1174852-552C-42F0-BD57-50733030D06BQ33871737-4F3E4975-71FB-4866-B61B-8EA3ABCB018FQ34019756-2FD8A8E0-9AB1-44E8-9825-173BC3AD589FQ34216839-91FC8678-66FA-438B-8D66-4B936B28EF01
P2860
Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Towards a glutamate hypothesis ...... harmacology for mood disorders
@ast
Towards a glutamate hypothesis ...... harmacology for mood disorders
@en
Towards a glutamate hypothesis ...... harmacology for mood disorders
@nl
type
label
Towards a glutamate hypothesis ...... harmacology for mood disorders
@ast
Towards a glutamate hypothesis ...... harmacology for mood disorders
@en
Towards a glutamate hypothesis ...... harmacology for mood disorders
@nl
prefLabel
Towards a glutamate hypothesis ...... harmacology for mood disorders
@ast
Towards a glutamate hypothesis ...... harmacology for mood disorders
@en
Towards a glutamate hypothesis ...... harmacology for mood disorders
@nl
P2093
P2860
P3181
P1433
P1476
Towards a glutamate hypothesis ...... harmacology for mood disorders
@en
P2093
Gerard Sanacora
Giulia Treccani
Maurizio Popoli
P2860
P3181
P356
10.1016/J.NEUROPHARM.2011.07.036
P407
P577
2012-01-01T00:00:00Z